A detailed history of O'Shaughnessy Asset Management, LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, O'Shaughnessy Asset Management, LLC holds 5,068 shares of EXAS stock, worth $218,785. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,068
Previous 5,547 8.64%
Holding current value
$218,785
Previous $410,000 14.88%
% of portfolio
0.0%
Previous 0.01%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$56.27 - $73.77 $26,953 - $35,335
-479 Reduced 8.64%
5,068 $349,000
Q4 2023

Feb 09, 2024

SELL
$59.06 - $75.72 $26,281 - $33,695
-445 Reduced 7.43%
5,547 $410,000
Q3 2023

Nov 13, 2023

BUY
$65.94 - $99.04 $21,826 - $32,782
331 Added 5.85%
5,992 $408,000
Q2 2023

Aug 11, 2023

BUY
$62.68 - $95.05 $17,926 - $27,184
286 Added 5.32%
5,661 $531,000
Q1 2023

May 12, 2023

BUY
$47.19 - $70.77 $53,419 - $80,111
1,132 Added 26.68%
5,375 $364,000
Q4 2022

Feb 10, 2023

BUY
$30.35 - $53.15 $128,775 - $225,515
4,243 New
4,243 $210,000
Q4 2021

Feb 11, 2022

SELL
$72.5 - $100.68 $3,407 - $4,731
-47 Closed
0 $0
Q3 2021

Nov 10, 2021

SELL
$90.24 - $124.05 $2,526 - $3,473
-28 Reduced 37.33%
47 $4,000
Q2 2021

Aug 09, 2021

SELL
$93.66 - $139.27 $21,354 - $31,753
-228 Reduced 75.25%
75 $9,000
Q1 2021

May 14, 2021

BUY
$116.57 - $155.01 $26,111 - $34,722
224 Added 283.54%
303 $40,000
Q4 2020

Feb 11, 2021

BUY
$99.61 - $142.12 $796 - $1,136
8 Added 11.27%
79 $10,000
Q3 2020

Nov 12, 2020

SELL
$72.92 - $102.01 $291 - $408
-4 Reduced 5.33%
71 $7,000
Q2 2020

Aug 13, 2020

BUY
$55.75 - $92.75 $4,181 - $6,956
75 New
75 $7,000
Q1 2020

May 13, 2020

SELL
$37.9 - $104.44 $1,591 - $4,386
-42 Closed
0 $0
Q4 2019

Feb 12, 2020

BUY
$77.66 - $99.74 $3,261 - $4,189
42 New
42 $4,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $7.64B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track O'Shaughnessy Asset Management, LLC Portfolio

Follow O'Shaughnessy Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.